Traders should base analysis on the underlying index (XBI), as LABU's price action is distorted by leverage-induced drift.

The Trump administration’s ambition to unleash biomedical innovation and sharpen America’s edge against China is colliding with a far messier reality inside the Food and Drug Administration. Investors ...

Pandorum Technologies, a Bengaluru-based biotechnology startup focused on tissue engineering, is raising Rs 85 crore (around $10 million) in its Series B round led by Protons Corporate, along with ...

The U.S. needs to up its game in protecting its biotech, quantum and foundational semiconductor supply chains so that China isn’t able to weaponize its dominance in these areas the way it did with ...

Manama, 27 October 2025: Bahrain Mumtalakat Holding Co. BSC(c), the sovereign wealth fund of the Kingdom of Bahrain, and SandboxAQ, which is focused on artificial intelligence and quantum techniques, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In recent months, Biogen has ...

Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Sana Biotechnology (SANA). The reason why I want to go over this biotech next is because it ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...